Cyrano Therapeutics
Cyrano Therapeutics is a regenerative medicine company developing treatments for smell loss. Their lead product, CYR-064, is an intranasal theophylline spray therapy aimed at treating post-viral hyposmia. The company is currently conducting a Phase 2 clinical trial to assess its safety and effectiveness.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $9.0M
Date: 16-Jan-2024
Investors: Florida Opportunity Fund (managed by DeepWork Capital), Lumira Ventures, Remiges Ventures
Markets: Regenerative Medicine, Biotechnology, Healthtech, Pharmaceutical Manufacturing, Drug Discovery, Pharmaceuticals
HQ: Delray Beach, Florida, United States
Founded: 2014
Website: https://cyranotherapeutics.com/
LinkedIn: https://www.linkedin.com/company/cyrano-therapeutics
Crunchbase: https://www.crunchbase.com/organization/cyrano-therapeutics
Leave a Comment
Comments
No comments yet.